Skip to contentGRYSKA DAVID W — SEATTLE GENETICS INC /WA insider: 276 transactions · InsiderLensGRYSKA DAVID W
- Director at SEATTLE GENETICS INC /WA · on record since Feb 15, 2006
- Director at COTHERIX INC · on record since May 26, 2006
- Chief Financial Officer at CELGENE CORP /DE/ · on record since Dec 8, 2006
- Director at AERIE PHARMACEUTICALS INC · on record since Oct 25, 2013
- Director at Myriad Pharmaceuticals, Inc. · on record since May 21, 2012
- Chief Operating Officer at Myriad Pharmaceuticals, Inc. · on record since May 21, 2012
- Director at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
- Director at Forte Biosciences, Inc. · on record since Jun 2, 2026
- Director at PDL BIOPHARMA, INC. · on record since Mar 10, 2014
- Director at ARGOS THERAPEUTICS INC · on record since Feb 6, 2014
- Director at Definium Therapeutics, Inc. · on record since Jun 15, 2026
- Executive Vice President, CFO at INCYTE CORP · on record since Nov 4, 2014
- Director at GW PHARMACEUTICALS PLC · on record since Sep 16, 2020
Insider trading activity of GRYSKA DAVID W
- Transactions on record
- 276
- since Dec 29, 2004
- Open-market buys
- 2
- $38.9K
- Open-market sells
- 45
- $23.7M
- Companies traded
- 10
- last filing Jun 15, 2026
Figures computed from official regulatory filings — methodology.
Companies where GRYSKA DAVID W has traded
- Definium Therapeutics, Inc.9 tx · $38.9K · Jun 15, 2026
- Forte Biosciences, Inc.6 tx · $150K · Jun 2, 2026
- SEATTLE GENETICS INC /WA134 tx · $24.6M · Dec 15, 2023
- AERIE PHARMACEUTICALS INC16 tx · $375.2K · Nov 21, 2022
- GW PHARMACEUTICALS PLC4 tx · May 7, 2021
- PDL BIOPHARMA, INC.19 tx · $2.9M · Dec 31, 2020
- INCYTE CORP45 tx · $14.6M · Jul 18, 2018
- HYPERION THERAPEUTICS INC1 tx · May 1, 2013
- CELGENE CORP /DE/36 tx · $7.1M · Jul 15, 2010
Track record of GRYSKA DAVID W
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of GRYSKA DAVID W
Co-insiders of GRYSKA DAVID W
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $141.3K · Jan 10, 2007
Baker Biotech Capital III (GP), LLCINCYTE CORP +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 15, 2026 | Award | 4,666 | 0.00 USD | $0 | SEC |
| Jun 15, 2026 | AwardD | 19,188 | 0.00 USD | $0 | SEC |
| Jun 2, 2026 | AwardD | 18,353 | 0.00 USD | $0 | SEC |
| Jun 16, 2025 | AwardD | 75,187 | 0.00 USD | $0 | SEC |
| Mar 21, 2025 | AwardD | 31,000 | 0.00 USD | $0 | SEC |
| Dec 5, 2024 | Buy | 2,500 | 7.17 USD | $17.9K | SEC |
| Aug 26, 2024 | Buy | 3,500 | 5.98 USD | $20.9K | SEC |
| Aug 22, 2024 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Jun 12, 2024 | AwardD | 16,506 | 0.00 USD | $0 | SEC |
| Dec 15, 2023 | Other | -49,003 | 229.00 USD | $11.2M | SEC |
| Dec 15, 2023 | OtherD | -3,462 | — | — | SEC |
| Dec 15, 2023 | OtherD | -9,260 | — | — | SEC |
| Dec 15, 2023 | OtherD | -3,676 | — | — | SEC |
| Dec 15, 2023 | OtherD | -9,260 | — | — | SEC |
| Dec 15, 2023 | OtherD | -9,260 | — | — | SEC |
| Dec 15, 2023 | OtherD | -2,044 | — | — | SEC |
| Dec 15, 2023 | OtherD | -7,038 | — | — | SEC |
| Dec 15, 2023 | OtherD | -9,260 | — | — | SEC |
| Dec 15, 2023 | OtherD | -3,171 | — | — | SEC |
| Dec 15, 2023 | OtherD | -8,750 | — | — | SEC |
| Sep 20, 2023 | AwardD | 25,000 | 0.00 USD | $0 | SEC |
| Aug 2, 2023 | Award | 148,514 | 1.01 USD | $150K | SEC |
| Jun 23, 2023 | Award | 13,851 | 0.00 USD | $0 | SEC |
| Jun 23, 2023 | AwardD | 37,594 | 0.00 USD | $0 | SEC |
| Jun 23, 2023 | AwardD | 13,131 | — | — | SEC |